Beijing Percutaneous Coronary Intervention Registry (BJPCI Registry)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2015 by Chinese Academy of Medical Sciences, Fuwai Hospital
Sponsor:
Information provided by (Responsible Party):
Yang yuejin, Cardiovascular Institute & Fuwai Hospital
ClinicalTrials.gov Identifier:
NCT01417325
First received: August 15, 2011
Last updated: July 27, 2015
Last verified: July 2015
  Purpose
The registry study is to obtain the state of the art of the percutaneous coronary intervention state treatment for coronary heart disease in Beijing area of P.R.China in a real world. The data are collected from 48 hospitals in Beijing area using an uploading system through internet.

Condition
Coronary Heart Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: A Registry Study of Percutaneous Coronary Intervention Treatment in Beijing Area of P.R. China

Resource links provided by NLM:


Further study details as provided by Chinese Academy of Medical Sciences, Fuwai Hospital:

Estimated Enrollment: 700000
Study Start Date: January 2010
Estimated Study Completion Date: December 2020
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All the patients receiving coronal artery angiography or percutaneous coronary intervention therapy in selected 48 hospitals of Beijing, P.R.China.
Criteria

Inclusion Criteria:

  • Patients from selected 48 hospitals of Beijing, P.R.China
  • Patients receiving coronal artery angiography or percutaneous coronary intervention therapy

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01417325

Contacts
Contact: Yuejin Yang, Doctor 8610-68314466 yangyjfw@yahoo.com.cn
Contact: Lei Song, Doctor 8610-13910968125 drsongfw@gmail.com

Locations
China, Beijing
Beijing cardiovascular intervention quality control and improvement center Recruiting
Beijing, Beijing, China, 100037
Contact: Yuejin Yang, doctor    8610-88398800    yangyjfw@yahoo.com.cn   
Contact: Lei Song, doctor    8610-13910968125    drsongfw@gmail.com   
Sponsors and Collaborators
Chinese Academy of Medical Sciences, Fuwai Hospital
Investigators
Study Chair: Yuejin Yang, doctor Fuwai Heart Hospital & Cardiovascular Institute
  More Information

Responsible Party: Yang yuejin, Director of coronary heart disease center, vice president of Fuwai hospital, Cardiovascular Institute & Fuwai Hospital
ClinicalTrials.gov Identifier: NCT01417325     History of Changes
Other Study ID Numbers: Bciqcic-fw-01 
Study First Received: August 15, 2011
Last Updated: July 27, 2015
Health Authority: China: Food and Drug Administration

Additional relevant MeSH terms:
Heart Diseases
Coronary Disease
Coronary Artery Disease
Myocardial Ischemia
Cardiovascular Diseases
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases

ClinicalTrials.gov processed this record on August 28, 2016